While pharmaceutical market researchers have benefited from comprehensive, secondary data sources and sophisticated analytics for years, the R&D functions and clinical research organizations (CROs) were on the outside looking in when it came to access to this information and analytical approach.
However, today R&D pharma executives and CROs can tap into these rich data resources to improve their patient recruiting productivity by identifying…
MS Patients in Germany Reduced by Exclusion Criteria
Michel Denarié, Leader, Center of Excellence, Customer Insights, IMS Health
Robert Kraft, Engagement Manager,IMS Health